Clinical trial
Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis
NCT00117208 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00117208 |
|---|---|
| Title | Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis |
| Official title | A Cross-Over Comparative Study of Inhaled Mannitol, Alone and in Combination With Daily rhDNase, in Children With Cystic Fibrosis |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | mannitol, mannitol + pulmozyme, Dornase alpha |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jul 4, 2005 |
| Last update posted | Feb 2, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: